Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured Program (the “Uninsured Program”) for overpayments for claims Signal submitted for patients who had health insurance.“When companies knowingly retain federal healthcare program funds they were not entitled to receive, they violate the public’s trust and the law,” said Assistant Attorney General
Source: Read Original Article